Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report

Complications - [c] Cardiac Disease and Lipid Therapy

Data on age, BMI, diabetes duration, gender, initial visit, indigenous status, currently pregnant individuals, smoking status and type of diabetes by treatment

Page last updated: December 2011

Table 27 shows the analysis of the Cholesterol levels [Target ≤ 4 mmol/l] and Lipid Therapy [LipRx] status of individuals reported to have ever had a Myocardial Infarct or CABG/Angioplasty. Of 623 individuals, 34.8% were above target despite 90.8% receiving Lipid Therapy [with mean Total Cholesterol 4.8 mmol/l and 9.2% not on Lipid Rx at all!].

Table 27 Cardiac Disease and Anti-Lipid Rx [Adult Forms Only]

Any Infarct, CABG or Stroke
Chol
LipRx
N
% in Category
%
Mean Chol
Mean HDL
Mean TG
Mean LDL
Chol >4
No
20
9.2%
5.0
1.2
1.8
2.8
Yes
197
90.8%
4.8
1.2
2.4
2.6
Total
217
34.8%
Chol ≤4
No
22
5.4%
3.5
1.2
1.2
1.7
Yes
384
94.6%
3.3
1.0
1.6
1.5
Total
406
65.2%
623
100.0%
Cardiac Disease is: the occurrence of CABG / Angioplasty and/or Myocardial Infarction, either in the past 12 months or previously [ie Any CABG or Infarct].

Document download

This publication is available as a downloadable document.

Australian National Diabetes Information Audit & Benchmarking (ANDIAB) 2011 Final Report(PDF 559 KB)